FOLH1 and neoplasm: Exclusive expression of PSMA in tumor neovasculature of solid tumors, but not in normal vessels, highlights PSMA not only as a target for radio-ligand or other conjugate therapy but also as an enzyme whose specific inhibition may have anti-angiogenic effects.